Analyst consensus rating

Quantum Biopharma Analyst Rating: none

Direct answer

Quantum Biopharma's consensus rating is none.

1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.17.
Forecast evidence checked November 21, 2026.

Get free Quantum Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.29
Average price target
$12.17
High price target
$12.17
Low price target
$12.17
Low target gap
+843.3%
Target upside
+843.3%
High target gap
+843.3%
Target range width
0%
Consensus rating
none
Analysts
1
Evidence date
November 21, 2026
Valid through
November 28, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Quantum Biopharma?

Quantum Biopharma has a verified none consensus. The same dataset has an average price target of $12.17.

How far are Quantum Biopharma's low and high targets from the recorded price?

The low target implies +843.3%, while the high target implies +843.3%.

How many analysts are included in Quantum Biopharma's consensus?

The verified consensus includes 1 analysts.

How is Quantum Biopharma's target upside or downside calculated?

The average target of $12.17 is divided by the recorded price of $1.29, then one is subtracted to produce +843.3%. This does not guarantee a future return.

When was Quantum Biopharma's analyst forecast verified?

The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.